Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,984 | -19,746 | -14,457 | -9,063 | -4,361 |
| Depreciation Amortization | 67 | 321 | 249 | 170 | 87 |
| Accounts payable and accrued liabilities | 367 | 25 | -854 | -669 | -292 |
| Other Working Capital | -1,984 | -451 | -1,547 | -2,093 | -1,490 |
| Other Operating Activity | 5,759 | -1,331 | 2,113 | 1,592 | 644 |
| Operating Cash Flow | $-9,775 | $-21,182 | $-14,496 | $-10,063 | $-5,412 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 500 | 500 | 500 | 500 |
| PPE Investments | -28 | -23 | -15 | -11 | N/A |
| Investing Cash Flow | $-28 | $477 | $485 | $489 | $500 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -495 | -2,474 | -1,714 | -1,256 | -571 |
| Common Stock Issued | 33 | 90 | 14 | 13 | 0 |
| Other Financing Activity | 0 | 39,545 | -42 | 0 | 0 |
| Financing Cash Flow | $-462 | $37,161 | $-1,742 | $-1,243 | $-571 |
| Exchange Rate Effect | 8 | N/A | 0 | N/A | N/A |
| Beginning Cash Position | 49,564 | 33,108 | 33,108 | 33,108 | 33,108 |
| End Cash Position | 39,307 | 49,564 | 17,355 | 22,291 | 27,625 |
| Net Cash Flow | $-10,257 | $16,456 | $-15,753 | $-10,817 | $-5,483 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,775 | -21,182 | -14,496 | -10,063 | -5,412 |
| Capital Expenditure | -28 | -23 | -15 | -11 | 0 |
| Free Cash Flow | -9,803 | -21,205 | -14,511 | -10,074 | -5,412 |